Search - tctmd.com

Displaying 881 - 900 of 1067

Sort: Relevancy | Date

Presentation

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

Presenter: Giovanna Sarno

July 01, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

Presentation

Causes of Early Stent Thrombosis in Patients with ACS: An Ex Vivo Human Autopsy Study

Presenter: M. Nakano

April 23, 2014

News Daily News

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

April 23, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

Presentation Fellows 2014

Stent Thrombosis and Restenosis

Presenter: Ajay Kirtane

April 13, 2014

Presentation

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Presenter: J.P. Loh

April 11, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

Presentation

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

Presenter: Philippe Généreux

April 02, 2014

News Conference News ACC 2014

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

April 02, 2014

Presentation ACC 2014

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

Presenter: Philippe Généreux

March 30, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

Majority of Short-term PCI Readmissions for Angina Concerns, not Complications

Jason Kahn

January 23, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Yael L. Maxwell

January 01, 2014

Advertisement

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

Causes of Early Stent Thrombosis in Patients with ACS: An Ex Vivo Human Autopsy Study

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Stent Thrombosis and Restenosis

Impact of Early vs Late Clopidogrel Discontinuation on Stent Thrombosis Following PCI with First- and Second-Generation DES

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Incidence and Impact of Stent Thrombosis after PCI: Comparison of Cangrelor and Clopidogrel

CHAMPION PHOENIX Analysis: Cangrelor Reduces Early Stent Thrombosis, Suggesting Mortality Benefit

Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Majority of Short-term PCI Readmissions for Angina Concerns, not Complications

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Similar Efficacy, Less Bleeding With Dabigatran vs. Warfarin in VTE Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content